SG11201502149YA - Coumarin derivative - Google Patents

Coumarin derivative

Info

Publication number
SG11201502149YA
SG11201502149YA SG11201502149YA SG11201502149YA SG11201502149YA SG 11201502149Y A SG11201502149Y A SG 11201502149YA SG 11201502149Y A SG11201502149Y A SG 11201502149YA SG 11201502149Y A SG11201502149Y A SG 11201502149YA SG 11201502149Y A SG11201502149Y A SG 11201502149YA
Authority
SG
Singapore
Prior art keywords
coumarin derivative
coumarin
derivative
Prior art date
Application number
SG11201502149YA
Inventor
Mitsuru Naiki
Tomoyuki Okada
Kazuyoshi Sawada
Takashi Ogino
Original Assignee
Nippon Zoki Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Zoki Pharmaceutical Co filed Critical Nippon Zoki Pharmaceutical Co
Publication of SG11201502149YA publication Critical patent/SG11201502149YA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/12Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 3 and unsubstituted in position 7
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/18Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted otherwise than in position 3 or 7
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
SG11201502149YA 2012-09-21 2013-09-20 Coumarin derivative SG11201502149YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012208656 2012-09-21
PCT/JP2013/075414 WO2014046224A1 (en) 2012-09-21 2013-09-20 Coumarin derivative

Publications (1)

Publication Number Publication Date
SG11201502149YA true SG11201502149YA (en) 2015-05-28

Family

ID=50341526

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201502149YA SG11201502149YA (en) 2012-09-21 2013-09-20 Coumarin derivative

Country Status (15)

Country Link
US (1) US9365533B2 (en)
EP (1) EP2899187B1 (en)
JP (1) JP6091016B2 (en)
KR (1) KR20150056544A (en)
CN (1) CN104640849B (en)
AU (1) AU2013318962B2 (en)
BR (1) BR112015005973A2 (en)
CA (1) CA2885262A1 (en)
ES (1) ES2630068T3 (en)
HK (1) HK1211918A1 (en)
IL (1) IL237823A (en)
RU (1) RU2646756C2 (en)
SG (1) SG11201502149YA (en)
TW (1) TWI583677B (en)
WO (1) WO2014046224A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106232116B (en) * 2014-03-20 2020-05-01 日本脏器制药株式会社 Therapeutic or prophylactic agent comprising coumarin derivative as active ingredient
JP6089055B2 (en) * 2014-03-20 2017-03-01 日本臓器製薬株式会社 Pharmaceuticals containing coumarin derivatives

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1523317A (en) * 1967-03-20 1968-05-03 Lipha New hydroxylated derivatives of coumarin and their preparation processes
FR2543140B1 (en) * 1983-03-24 1985-06-21 Cortial NOVEL FLAVONE-CARBOXYLIC ACIDS-4 ', THEIR PREPARATION METHOD AND THEIR APPLICATION IN THERAPEUTICS
RU2036917C1 (en) * 1989-11-28 1995-06-09 Санкио Компани Лимитед Coumarin derivatives or their pharmaceutically acceptable salt
CA2089372A1 (en) * 1990-09-28 1993-03-25 Pharmacia & Upjohn Company Anthelmintic and anticoccidial 3-carbamoyl-4-hydroxycoumarins, method of use and compositions
US5922755A (en) 1993-04-09 1999-07-13 Toyama Chemical Co., Ltd. Immunomodulator, cell adhesion inhibtor, and agent for treating, and preventing autoimmune diseases
EP0807629B1 (en) * 1996-05-15 2004-03-03 Aventis Pharma Deutschland GmbH Sulfonamido substituted chromane derivatives, method for their preparation, their use as medicaments or diagnostic agents aswell as medicaments containing them
US6191164B1 (en) * 1996-05-15 2001-02-20 Hoechst Aktiengesellschaft Sulfonamide-substituted chromans, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them
JP4658512B2 (en) * 2004-04-27 2011-03-23 日本臓器製薬株式会社 Coumarin derivative and Maillard reaction inhibitor containing the derivative
DE102004063910B4 (en) * 2004-07-05 2006-12-28 Bioplanta Arzneimittel Gmbh Trisubstituted benzopyranones and plant extracts and compositions containing them
WO2009014100A1 (en) * 2007-07-20 2009-01-29 Chugai Seiyaku Kabushiki Kaisha p27 PROTEIN INDUCER

Also Published As

Publication number Publication date
TW201418239A (en) 2014-05-16
RU2015114480A (en) 2016-11-10
JPWO2014046224A1 (en) 2016-08-18
ES2630068T3 (en) 2017-08-17
TWI583677B (en) 2017-05-21
US20150232440A1 (en) 2015-08-20
CA2885262A1 (en) 2014-03-27
US9365533B2 (en) 2016-06-14
WO2014046224A1 (en) 2014-03-27
BR112015005973A2 (en) 2017-07-04
EP2899187B1 (en) 2017-04-19
CN104640849A (en) 2015-05-20
JP6091016B2 (en) 2017-03-08
AU2013318962A1 (en) 2015-04-16
RU2646756C2 (en) 2018-03-07
HK1211918A1 (en) 2016-06-03
EP2899187A4 (en) 2016-06-29
IL237823A (en) 2017-05-29
CN104640849B (en) 2016-10-26
EP2899187A1 (en) 2015-07-29
KR20150056544A (en) 2015-05-26
AU2013318962B2 (en) 2017-03-02

Similar Documents

Publication Publication Date Title
HUS2200040I1 (en) Benzimidazole-proline derivatives
HK1205740A1 (en) Pyrrolotriazinone derivatives
HK1207375A1 (en) Piperidinylpyrazolopyridine derivative
HK1207363A1 (en) Novel indanesulfamide derivative
AP2015008347A0 (en) Oxazolidin-2-one-pyrimidine derivatives
HK1208817A1 (en) Chromane compounds
HK1200824A1 (en) Substituted phenylazole derivative
HK1197062A1 (en) Chromene compound
PT2873660T (en) Indolecarboxamide derivative
EP2821404A4 (en) Chroman derivative
EP2842958A4 (en) Naphthobisthiadiazole derivative
SG11201404325VA (en) Pyrimidooxazocine derivatives as mtor - inhibitors
HK1211918A1 (en) Coumarin derivative
HK1204621A1 (en) 4-alkanoylamino-3-pyrazolone derivative 4--3-